Organon & Co. · NYSE:OGN

Walsh Matthew M exercised options for 33,593 Organon & Co. shares (Form 4)

Traded Mar 31, 2026 · Filed Apr 2, 2026

On Mar 31, 2026, Walsh Matthew M (Chief Financial Officer) exercised options for 33,593 Organon & Co. shares, leaving 212,746 shares. Filed Apr 2, 2026 (Form 4).

Options exercised
33,593 shares
Holding after
212,746 shares
Trading plan
No
Role
Chief Financial Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Mar 31, 2026Common StockOption exercise12,047202,707Direct
Mar 31, 2026Common StockShares withheld for tax4,127US$5.70198,580Direct
Mar 31, 2026Common StockOption exercise21,546220,126Direct
Mar 31, 2026Common StockShares withheld for tax7,380US$5.70212,746Direct

Source

View original at SEC

Related